Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial.

Andrew H WeiHartmut DöhnerHamid Sayar Farhad RavandiPau MontesinosHervé DombretDominik SelleslagKimmo PorkkaJun-Ho JangBarry SkikneC L BeachThomas PrebetGeorge ZhangAlberto RisueñoManuel UgidosWendy L SeeDaniel MenezesGail J Roboz

Published in: American journal of hematology (2023)

Keyphrases

acute myeloid leukemia
placebo controlled
phase iii
double blind
phase ii
study protocol
clinical trial
allogeneic hematopoietic stem cell transplantation
open label
phase ii study
locally advanced
disease activity
randomized controlled trial
ulcerative colitis
chemotherapy induced
systemic lupus erythematosus